SPARC Intraday Analysis...

SPARC Share Price

Open 410.60 Change Price %
High 413.00 1 Day -12.40 -3.02
Low 395.75 1 Week -6.80 -1.68
Close 398.20 1 Month -25.90 -6.11
Volume 173213 1 Year 70.75 21.61
52 Week High 532.00
52 Week Low 272.00
SPARC Important Levels
Resistance 2 414.19
Resistance 1 407.60
Pivot 402.32
Support 1 388.80
Support 2 382.21
NSE INDIA Most Active Stocks
JPASSOCIAT 20.85 8.59%
IDBI 78.95 0.13%
RCOM 23.45 -0.64%
PNB 98.85 0.30%
SUZLON 11.70 0.43%
GMRINFRA 17.95 -2.71%
GTLINFRA 3.25 4.84%
ICICIBANK 298.10 -1.11%
SBIN 252.30 -0.55%
MMTC 67.20 8.21%
NSE INDIA Top Gainers Stocks
UVSL 0.20 33.33%
KSERASERA 0.25 25.00%
GSS 63.00 19.66%
GSS 63.00 19.66%
GSS 63.00 19.66%
GSS 63.00 19.66%
RAJRAYON 0.40 14.29%
RUCHISOYA 18.45 10.15%
TARAJEWELS 13.65 9.64%
ITDC 493.05 9.31%
NSE INDIA Top Losers Stocks
VISESHINFO 0.15 -25.00%
BLUECHIP 0.15 -25.00%
FCSSOFT 0.35 -12.50%
SPYL 0.45 -10.00%
FORTUNEFIN 231.00 -6.48%
BASML 256.85 -6.40%
AIAENG 1347.05 -6.32%
GDL 191.70 -6.24%
GDL 191.70 -6.24%
GDL 191.70 -6.24%

Sun Pharma Advanced Research Company Limited (NSE: SPARC)

SPARC Technical Analysis 2
As on 16th Mar 2018 SPARC Share Price closed @ 398.20 and we RECOMMEND Buy for LONG-TERM with Stoploss of 384.17 & Strong Sell for SHORT-TERM with Stoploss of 458.71 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPARC Target for March
1st Target up-side 479.85
2nd Target up-side 518.05
3rd Target up-side 556.25
1st Target down-side 370.85
2nd Target down-side 332.65
3rd Target down-side 294.45
SPARC Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 35.52 Sideways
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 14.57 Range Bound
PSAR Stoploss For Short Sell 448.09
10 Day Avg Volume Traded -28.28 % Less then 10 Day Average Volume
SPARC Other Details
Segment EQ
Market Capital 8430601728.00
Sector Healthcare
Industry Drugs - Generic
Offical website
SPARC Address
Sun Pharma Advanced Research Centre
Akota Road
Vadodara, 390020
Interactive Technical Analysis Chart Sun Pharma Advanced Research Company Limited ( SPARC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Sun Pharma Advanced Research Company Limited
SPARC Business Profile
Sun Pharma Advanced Research Company Limited operates as a pharma research and drug discovery company. It develops SUN 1334H, which has completed phase II clinical studies, used in the treatment of allergic disorders, such as seasonal and perennial allergic rhinitis, urticaria, hay fever, conjunctivitis, and pruritis; and Sun K706, a novel tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia. The company also offers SUN-597, an anti-inflammatory glucocorticoid that has completed preclinical development used for the treatment of allergic rhinitis, inflammation, asthma, and other applications; and Sun 44, a prodrug of gabapentin for the treatment of epilepsy, as well as for the treatment of neuropathic pain, restless leg syndrome, and mood disorders. In addition, it provides SUN-09, a prodrug of baclofen that has completed phase I studies for the treatment of spasticity; and SUN-L731, an oral LTD4 antagonist for asthma and allergic rhinitis. Further, the company offers gastro retentive innovative device, a once-a-day delivery system for drugs; wrap matrix oral delivery system; paclitaxel injection concentrate for nanodispersion for the treatment of breast cancer; docetaxel injection concentrate for nanodispersion for non-small cell lung cancer; and octreotide depot injections for treatment of prostate cancer and acromegaly. Additionally, the company provides salmeterol and fluticasone dry powder inhaler, a pre-metered inhalation activated device for administration of inhaled steroids and bronchodilator drugs for the treatment of asthma and COPD; swollen micelle microemulsion technology, a platform technology for solubilising ophthalmic drugs with limited or no water solubility; and gel free reservoir technology used for the treatment of chronic eye ailments, such as glaucoma. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.